2010
DOI: 10.1016/j.clay.2010.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Current challenges in clay minerals for drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
142
0
10

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 311 publications
(154 citation statements)
references
References 25 publications
0
142
0
10
Order By: Relevance
“…191 Although pristine silicates have been widely used as carriers of several drugs, polysaccharide-clay hybrids offer more advantages related to the enhanced stability of drug-loaded hybrid suspensions, higher drug encapsulation efficiency, modulation of ion exchange behaviour, swelling capacity or improved cellular uptake. 192 The non-cytotoxicity of polysaccharide-silicate nanoparticles has been also confirmed, as in the case of quaternized chitosan/clay nanocomposites, which were successfully applied for delivery of proteins 193 and also as a novel non-viral gene carrier, affording good transfection efficiency in both in vitro and in vivo experiments. 194 Clay minerals assembled to polysaccharides afford suitable materials for application in regenerative medicine, being provided with good mechanical properties and biocompatibility, and are an alternative to commonly employed hydroxyapatite (HAP) and other calcium phosphates.…”
mentioning
confidence: 86%
“…191 Although pristine silicates have been widely used as carriers of several drugs, polysaccharide-clay hybrids offer more advantages related to the enhanced stability of drug-loaded hybrid suspensions, higher drug encapsulation efficiency, modulation of ion exchange behaviour, swelling capacity or improved cellular uptake. 192 The non-cytotoxicity of polysaccharide-silicate nanoparticles has been also confirmed, as in the case of quaternized chitosan/clay nanocomposites, which were successfully applied for delivery of proteins 193 and also as a novel non-viral gene carrier, affording good transfection efficiency in both in vitro and in vivo experiments. 194 Clay minerals assembled to polysaccharides afford suitable materials for application in regenerative medicine, being provided with good mechanical properties and biocompatibility, and are an alternative to commonly employed hydroxyapatite (HAP) and other calcium phosphates.…”
mentioning
confidence: 86%
“…5 MMT has been used recently as an excipient in pharmaceutical applications, including transdermal formulations, tablets for oral administration, and as an extended release agent for tablets. [6][7][8][9][10] Furthermore, inclusion of photodegradable drug molecules within MMT may increase the photostability. 11 In this context, we further explore possible use of 3 MMT as a pharmaceutical excipient.…”
Section: Introductionmentioning
confidence: 99%
“…As argilas já podem ser encontradas em diversos medicamentos como componentes fundamentais, seja como excipiente ou até mesmo como insumo farmacêutico ativo (IFA), já que algumas argilas também possuem atividade biológica [3,21].…”
Section: Argilas Tubularesunclassified